Tag: Clinical Research
-
Shorter Dual Antiplatelet Therapy for Myocardial Infarction Patients
Dual antiplatelet therapy (DAPT) is a cornerstone in the management of patients who have experienced a myocardial infarction (MI), commonly known as a heart attack. Traditionally, the standard duration for DAPT has been 12 months following an MI to prevent thrombotic events. However, recent clinical research suggests that a shorter duration of DAPT, specifically three…